Literature DB >> 33439104

Gut microbiome-based supervised machine learning for clinical diagnosis of inflammatory bowel diseases.

Ishan Manandhar1, Ahmad Alimadadi1, Sachin Aryal1, Patricia B Munroe2, Bina Joe1, Xi Cheng1.   

Abstract

Despite the availability of various diagnostic tests for inflammatory bowel diseases (IBD), misdiagnosis of IBD occurs frequently, and thus, there is a clinical need to further improve the diagnosis of IBD. As gut dysbiosis is reported in patients with IBD, we hypothesized that supervised machine learning (ML) could be used to analyze gut microbiome data for predictive diagnostics of IBD. To test our hypothesis, fecal 16S metagenomic data of 729 subjects with IBD and 700 subjects without IBD from the American Gut Project were analyzed using five different ML algorithms. Fifty differential bacterial taxa were identified [linear discriminant analysis effect size (LEfSe): linear discriminant analysis (LDA) score > 3] between the IBD and non-IBD groups, and ML classifications trained with these taxonomic features using random forest (RF) achieved a testing area under the receiver operating characteristic curves (AUC) of ∼0.80. Next, we tested if operational taxonomic units (OTUs), instead of bacterial taxa, could be used as ML features for diagnostic classification of IBD. Top 500 high-variance OTUs were used for ML training, and an improved testing AUC of ∼0.82 (RF) was achieved. Lastly, we tested if supervised ML could be used for differentiating Crohn's disease (CD) and ulcerative colitis (UC). Using 331 CD and 141 UC samples, 117 differential bacterial taxa (LEfSe: LDA score > 3) were identified, and the RF model trained with differential taxonomic features or high-variance OTU features achieved a testing AUC > 0.90. In summary, our study demonstrates the promising potential of artificial intelligence via supervised ML modeling for predictive diagnostics of IBD using gut microbiome data.NEW & NOTEWORTHY Our study demonstrates the promising potential of artificial intelligence via supervised machine learning modeling for predictive diagnostics of different types of inflammatory bowel diseases using fecal gut microbiome data.

Entities:  

Keywords:  Crohn’s disease; gut microbiome; inflammatory bowel disease; machine learning; ulcerative colitis

Mesh:

Year:  2021        PMID: 33439104      PMCID: PMC8828266          DOI: 10.1152/ajpgi.00360.2020

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  56 in total

1.  IBD: Poor outcomes after Clostridium difficile infection in IBD.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-01       Impact factor: 46.802

Review 2.  Supervised classification of human microbiota.

Authors:  Dan Knights; Elizabeth K Costello; Rob Knight
Journal:  FEMS Microbiol Rev       Date:  2010-10-07       Impact factor: 16.408

3.  Large sample size, wide variant spectrum, and advanced machine-learning technique boost risk prediction for inflammatory bowel disease.

Authors:  Zhi Wei; Wei Wang; Jonathan Bradfield; Jin Li; Christopher Cardinale; Edward Frackelton; Cecilia Kim; Frank Mentch; Kristel Van Steen; Peter M Visscher; Robert N Baldassano; Hakon Hakonarson
Journal:  Am J Hum Genet       Date:  2013-05-23       Impact factor: 11.025

Review 4.  Crohn's disease.

Authors:  Daniel C Baumgart; William J Sandborn
Journal:  Lancet       Date:  2012-08-20       Impact factor: 79.321

Review 5.  The gut microbiota in IBD.

Authors:  Chaysavanh Manichanh; Natalia Borruel; Francesc Casellas; Francisco Guarner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-08-21       Impact factor: 46.802

6.  Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease.

Authors:  Wei Wang; Liping Chen; Rui Zhou; Xiaobing Wang; Lu Song; Sha Huang; Ge Wang; Bing Xia
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

7.  Human gut microbiome viewed across age and geography.

Authors:  Tanya Yatsunenko; Federico E Rey; Mark J Manary; Indi Trehan; Maria Gloria Dominguez-Bello; Monica Contreras; Magda Magris; Glida Hidalgo; Robert N Baldassano; Andrey P Anokhin; Andrew C Heath; Barbara Warner; Jens Reeder; Justin Kuczynski; J Gregory Caporaso; Catherine A Lozupone; Christian Lauber; Jose Carlos Clemente; Dan Knights; Rob Knight; Jeffrey I Gordon
Journal:  Nature       Date:  2012-05-09       Impact factor: 49.962

Review 8.  The gut microbiota and inflammatory bowel disease.

Authors:  Katsuyoshi Matsuoka; Takanori Kanai
Journal:  Semin Immunopathol       Date:  2014-11-25       Impact factor: 9.623

Review 9.  Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients.

Authors:  Mario Matijašić; Tomislav Meštrović; Mihaela Perić; Hana Čipčić Paljetak; Marina Panek; Darija Vranešić Bender; Dina Ljubas Kelečić; Željko Krznarić; Donatella Verbanac
Journal:  Int J Mol Sci       Date:  2016-04-19       Impact factor: 5.923

10.  Increased abundance of proteobacteria in aggressive Crohn's disease seven years after diagnosis.

Authors:  M K Vester-Andersen; H C Mirsepasi-Lauridsen; M V Prosberg; C O Mortensen; C Träger; K Skovsen; T Thorkilgaard; C Nøjgaard; I Vind; K A Krogfelt; N Sørensen; F Bendtsen; A M Petersen
Journal:  Sci Rep       Date:  2019-09-17       Impact factor: 4.379

View more
  4 in total

1.  Gut microbiota of wild fish as reporters of compromised aquatic environments sleuthed through machine learning.

Authors:  John W Turner; Xi Cheng; Nilanjana Saferin; Ji-Youn Yeo; Tao Yang; Bina Joe
Journal:  Physiol Genomics       Date:  2022-04-20       Impact factor: 4.297

2.  A Systematic Review of Artificial Intelligence and Machine Learning Applications to Inflammatory Bowel Disease, with Practical Guidelines for Interpretation.

Authors:  Imogen S Stafford; Mark M Gosink; Enrico Mossotto; Sarah Ennis; Manfred Hauben
Journal:  Inflamm Bowel Dis       Date:  2022-10-03       Impact factor: 7.290

3.  Can the Salivary Microbiome Predict Cardiovascular Diseases? Lessons Learned From the Qatari Population.

Authors:  Selvasankar Murugesan; Mohammed Elanbari; Dhinoth Kumar Bangarusamy; Annalisa Terranegra; Souhaila Al Khodor
Journal:  Front Microbiol       Date:  2021-12-10       Impact factor: 5.640

4.  Characteristics of Fecal Microbiota and Machine Learning Strategy for Fecal Invasive Biomarkers in Pediatric Inflammatory Bowel Disease.

Authors:  Xinqiong Wang; Yuan Xiao; Xu Xu; Li Guo; Yi Yu; Na Li; Chundi Xu
Journal:  Front Cell Infect Microbiol       Date:  2021-12-07       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.